NEW ANTI-COCAINE VACCINE RESEARCH SHOWS DRUG CAN’T REACH THE BRAIN, HUMAN CLINICAL TRIALS ON THE HORIZON
Researchers at Weill Cornell Medical College have successfully tested their novel anti-cocaine vaccine in primates, bringing them closer to launching human clinical trials.
Their study, published online by the journal Neuropsychopharmacology, used a radiological technique to demonstrate that the anti-cocaine vaccine prevented the drug from reaching the brain and producing a dopamine-induced high.
“The vaccine eats up the cocaine in the blood like a little Pac-man before it can reach the brain,” says the study’s lead investigator, Dr. Ronald G. Crystal, chairman of the Department of Genetic Medicine at Weill Cornell Medical College.
“We believe this strategy is a win-win for those individuals, among the estimated 1.4 million cocaine users in the United States, who are committed to breaking their addiction to the drug,” he says. “Even if a person who receives the anti-cocaine vaccine falls off the wagon, cocaine will have no effect.”
Dr. Crystal says he expects to begin human testing of the anti-cocaine vaccine within a year.
Cocaine, a tiny molecule drug, works to produce feelings of pleasure because it blocks the recycling of dopamine — the so-called “pleasure” neurotransmitter — in two areas of the brain, the putamen in the forebrain and the caudate nucleus in the brain’s center. When dopamine accumulates at the nerve endings, “you get this massive flooding of dopamine and that is the feel good part of the cocaine high,” says Dr. Crystal.
The novel vaccine Dr. Crystal and his colleagues developed combines bits of the common cold virus with a particle that mimics the structure of cocaine. When the vaccine is injected into an animal, its body “sees” the cold virus and mounts an immune response against both the virus and the cocaine impersonator that is hooked to it. “The immune system learns to see cocaine as an intruder,” says Dr. Crystal. “Once immune cells are educated to regard cocaine as the enemy, it produces antibodies, from that moment on, against cocaine the moment the drug enters the body.”
In their first study in animals, the researchers injected billions of their viral concoction into laboratory mice, and found a strong immune response was generated against the vaccine. Also, when the scientists extracted the antibodies produced by the mice and put them in test tubes, it gobbled up cocaine. They also saw that mice that received both the vaccine and cocaine were much less hyperactive than untreated mice given cocaine.
BOOSTER SHOTS TO DAMPEN THE COCAINE HIGH
In this study, the researchers sought to precisely define how effective the anti-cocaine vaccine is in non-human primates, who are closer in biology to humans than mice.
They developed a tool to measure how much cocaine attached to the dopamine transporter, which picks up dopamine in the synapse between neurons and brings it out to be recycled. If cocaine is in the brain, it binds on to the transporter, effectively blocking the transporter from ferrying dopamine out of the synapse, keeping the neurotransmitter active to produce a drug high.
In the study, the researchers attached a short-lived isotope tracer to the dopamine transporter. The activity of the tracer could be seen using positron emission tomography (PET). The tool measured how much of the tracer attached to the dopamine receptor in the presence or absence of cocaine.
The PET studies showed no difference in the binding of the tracer to the dopamine transporter in vaccinated compared to unvaccinated animals if these two groups were not given cocaine. But when cocaine was given to the primates, there was a significant drop in activity of the tracer in non-vaccinated animals. That meant that without the vaccine, cocaine displaced the tracer in binding to the dopamine receptor. Previous research had shown in humans that at least 47 percent of the dopamine transporter had to be occupied by cocaine in order to produce a drug high. The researchers found, in vaccinated primates, that cocaine occupancy of the dopamine receptor was reduced to levels of less than 20 percent.
“This is a direct demonstration in a large animal, using nuclear medicine technology, that we can reduce the amount of cocaine that reaches the brain sufficiently so that it is below the threshold by which you get the high,” says Dr. Crystal.
When the vaccine is studied in humans, the non-toxic dopamine transporter tracer can be used to help study its effectiveness as well, he adds.
The Latest Bing News on:
- As fatal drug overdoses continue to rise in Virginia, new record could be set this yearon November 23, 2021 at 9:02 pm
Virginia is headed toward another record number of drug overdose deaths, which experts blame on social isolation and stress associated with the COVID-19 pandemic and widespread trafficking of fentanyl ...
- Coast Guard To Offload $504 Million In Cocaine, Marijuana At Port Evergladeson November 22, 2021 at 9:10 am
The US Coast Guard is scheduled to offload millions of dollars of drugs at Port Everglades on Monday morning which was intercepted at sea.
- 🌱 Barnard's Schwinn Back In Business + Latest Vaccine Numberson November 20, 2021 at 2:07 pm
The Daily is made possible by local business Focus Point Training. 2. A survey about how Oak Park should spend its American Rescue Plan funds yielded only about 200 responses. Trustees say they need ...
- Jordan Roman Brennan, 28, and Brendan John Sipple, 26, charged with two counts of possessing a commercial quantity of cocaineon November 18, 2021 at 6:12 am
The boyfriend of anti-vax Instagram “influencer” Kate Szepanowski fronted court today charged over one of Queensland’s biggest cocaine busts, with police alleging he was involved in the importation of ...
- $53 million worth of cocaine, meth and pot seized at Laredo border crossingon November 16, 2021 at 11:53 pm
A pair of drug busts at a Texas border crossing netted nearly two tons of narcotics with an estimated street value of more than $53 million.
- Georgia man sold guns, cocaine to undercover cop in NYC; 25 guns seizedon November 16, 2021 at 11:42 am
Authorities busted a gun-trafficking pipeline after a man from Georgia allegedly sold 25 guns and cocaine to an undercover officer. Yamil Torres-Rincon, 24, was taken into custody ...
- Man arrested for trying to smuggle cocaine into Steuben County Jailon November 15, 2021 at 10:35 am
A Genesee County man has been arrested for attempting to smuggle cocaine into the Steuben County Jail. Alexander Gravesandy, 31, from Le Roy, N.Y., was arrested by ...
- Huge catch: $44 million worth cocaine found in onion ring cargo at UK borderon November 15, 2021 at 3:42 am
In a huge illicit drugs seizure, a shipment of cocaine worth $44 million (£33 million) was found in an onion ring cargo in Coquelles, France, said officials at the UK border. According to the country ...
- Peabody Man Charged In Essex Cocaine Bust: Policeon November 9, 2021 at 11:09 am
A Peabody man was charged with cocaine trafficking after Essex police ... Police searched the Jeep and said they found the coronavirus vaccine card, flight ticket to the Dominican Republic for ...
- Kinder Surprise: Newcastle drug dealer left cocaine in Kinder Egg at covid vaccination centreon November 9, 2021 at 12:18 am
Surprised vaccination centre staff found a Kinder Egg full of cocaine when a drug dealer left ... for his covid vaccine in March when he dropped the drug-filled egg. Suspicious staff noticed ...
The Latest Google Headlines on:
The Latest Bing News on:
- Trump Would've Already Made a Vaccine for Omicron Variant, Stephen Miller Claimson November 27, 2021 at 2:58 pm
It took the Trump Administration 11 months to develop its first COVID-19 vaccine after the first confirmed coronavirus case emerged in the United States.
- Drug firm Moderna to develop booster shot against new threaton November 27, 2021 at 9:40 am
The US pharmaceutical company Moderna said it will develop a booster shot against the new Omicron variant of the coronavirus.
- Single dose of HPV vaccine may be enough for protection, trial suggestson November 26, 2021 at 8:25 am
Women getting vaccinated against the cancer-causing human papillomavirus now need two or three shots, but an African clinical trial suggests a single dose is just as effective.
- A Key West doctor who participated in a Florida anti-vaccination summit now has COVIDon November 25, 2021 at 7:48 am
Seven doctors who gathered at a COVID anti-vaccination summit in Florida to tout the anti-parasitic drug ivermectin and other alternative measures for preventing the transmission of the coronavirus ...
- Seven doctors contract Covid after attending anti-vaccine summit in Floridaon November 24, 2021 at 9:15 am
Among those who fell include a 71-year-old doctor who said that he and his wife have been taking ivermectin tablets for 16 months as a precaution against COVID-19 ...
- Seven From Anti-Vax Doctors’ COVID Conference Fall Sick Within Dayson November 23, 2021 at 2:03 am
Beast/Photos YouTubeTo hear the fringe doctors who gathered at an equine facility for the Florida COVID Summit earlier this month, ivermectin is as effective against the virus in humans as it is ...
- AstraZeneca announces 'robust' results from anti-COVID drug trialon November 18, 2021 at 11:59 am
Pharmaceutical giant AstraZeneca on Thursday announced that clinical trials of an antibody-based COVID-19 drug had shown robust efficacy and long-term prevention.
- ‘Robust’ results from anti-Covid drug trial, announces AstraZenecaon November 18, 2021 at 11:08 am
Pharmaceutical giant AstraZeneca on Thursday announced that clinical trials of an antibody-based Covid-19 drug had shown robust efficacy and long-term prevention.The Anglo-Swedish laboratory follows ...
- Hampton Roads health officials issue warnings about anti-parasite drug Ivermectinon November 16, 2021 at 2:18 pm
Sentara Healthcare is due in court later this week as a physician is challenging the health care giant over the drug Ivermectin. When used properly on livestock and humans, Ivermectin can address ...
- Anti-platelet drug class fails to extend survival in moderately ill COVID-19 patientson November 15, 2021 at 3:32 pm
A drug class that blocks the activity of blood platelets and prevents clotting—P2Y12 inhibitors—failed to extend survival or lessen disease severity in patients with COVID-19 who were hospitalized but ...